Programming of Epigenetic Clocks and Biomarkers from Early-life Arsenic Exposure
Programming of Epigenetic Clocks and Biomarkers from Early-life Arsenic Exposure
批准号:
10726009
负责人:
Andres Cardenas
金额:
$20.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-07 至 2025-08-31
关键词:
AccelerationAddressAdultAgeAgingAreaArsenicBiochemicalBiologicalBiological AgingBiological MarkersBiological ProcessBirthBlood specimenBody mass indexBronchiectasisCarcinogensCardiovascular DiseasesCellsChileChronic DiseaseChronic Kidney FailureChronologyCitiesDNA MethylationDataDevelopmentDiabetes MellitusDietDiseaseDisease susceptibilityDyslipidemiasEarly identificationEnvironmental Risk FactorEpigenetic ProcessExposure toGenesHealthHealth behaviorHumanHuman GenomeImmuneImmune systemImpaired cognitionIncidenceIndividualInflammationInsulin ResistanceInvestigationLeukocytesLifeLinkLong-Term EffectsLongevityMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of urinary bladderMeasurementMeasuresMonitorMorbidity - disease rateMyocardial InfarctionNatural experimentParticipantPersonsPlantsPopulationPreventionRecordsRenal carcinomaReportingRespiratory DiseaseRespiratory Signs and SymptomsRestRiskSamplingSiteSmokingSocioeconomic StatusSomatic CellSourceSystems DevelopmentTestingTissuesToxic effectUnited StatesVariantWaterWorkWorld Health Organizationage relatedclinically relevantcohortcontaminated drinking waterdisorder riskdrinking waterearly childhoodearly detection biomarkersearly life exposureepidemiology studyepigenetic markerfollow-upfrailtyhuman dataimmunoregulationin uteromiddle agemortalitymortality riskprenatal exposureprogramsprospectiverespiratorysexurinarywater treatment
中文摘要
项目摘要
全世界有数百万人暴露于砷,主要来自受污染的饮用水源,
砷是一种已知的人类致癌物质,暴露一直是
与其他慢性疾病相关,包括糖尿病、心血管和呼吸系统疾病风险,
新出现的证据突出了其免疫调节作用。有证据表明砷暴露
影响表观遗传编程,并提出砷暴露和潜伏期之间的潜在联系
许多相关的健康影响,包括癌症。关于砷的毒性可能涉及
表观遗传失调主要在成人横断面和出生队列中进行了测试,随访有限
以测试表观遗传变化的持续性或临床相关性。拟议项目将
利用智利北方最大城市安托法加斯塔的一项大型流行病学研究的样本和数据,
那里有大量的砷水浓度记录。1958年,两条砷含量高的河流
作为饮用水的主要来源被转移到研究区域,
1970年,一个含砷的水处理厂建成。因此,有一个13年的时间,
平均砷浓度为860微克/升,在治疗前后的水平要低得多(<10微克/升)。
期这一悲惨的场景提供了一个自然的实验来研究人类健康影响的潜伏期
与智利其他地区的有效比较人群接触高水平的砷。研究从这个
地区报告了强烈的前瞻性关联和证据表明,早期生活中的砷暴露与
随着肺癌、膀胱癌和肾癌的增加以及心肌梗死风险的增加,
肾病、支气管扩张和呼吸道症状。这些关联在几十年后才变得明显
在采取缓解措施后,
满员你我们正在利用已经收集的样本,这些样本来自于在生命早期暴露和未暴露的个体。
匹配研究参与者,以测试几十年后中年(中位年龄)时表观遗传破坏的持续性
~ 50年)。我们将评估暴露个体是否在多种表观遗传学中加速了表观遗传衰老,
反映生物老化、发病率和死亡率风险的不同方面的时钟。此外,我们将测试是否
接触者对白细胞组成和DNA甲基化特征的估计不同。我们将
关键协变量的匹配和控制,如当前尿砷水平,
成年、饮食、吸烟、BMI、性别和社会经济地位。这种方法将使我们能够测试延迟
白细胞DNA甲基化中捕获的表观遗传破坏与最近和当前的砷无关
exposure.如果成功的话,我们的研究将证明,在生命早期接触砷可以持续
程序表观遗传生物标志物与发病率和死亡率密切相关几十年后。
英文摘要
PROJECT SUMMARY
Millions of individuals around the world are exposed to arsenic, mostly from contaminated drinking water sources,
including many areas in the U.S. Arsenic is a known human carcinogen, and exposure has been consistently
associated with other chronic diseases including diabetes, cardiovascular and respiratory disease risk with
emerging evidence highlighting its immunomodulatory effects. There is evidence that arsenic exposure
influences epigenetic programming and proposed to be a potential link between arsenic exposure and the latency
of many associated health effects, including cancer. The leading hypothesis that arsenic’s toxicity might involve
epigenetic dysregulation has been tested mostly in adult cross-sectional and birth cohorts with limited follow-up
of participants to test for persistence or clinical relevance of epigenetic changes. The proposed project will
leverage samples and data from a large epidemiological study in Antofagasta, the largest city in Northern Chile,
where extensive arsenic water concentration records exist. In 1958, two rivers with high arsenic concentrations
were diverted into the study region as the primary source of drinking water and this high exposure period ended
in 1970 when an arsenic water treatment plant was installed. As a result, there was a thirteen-year period in
which average arsenic concentrations were 860 µg/L, with much lower levels (<10 µg/L) before and after the
period. This tragic scenario provided a natural experiment to study the latency of health effects among people
exposed to high levels of arsenic with valid comparison populations from the rest of Chile. Studies from this
region have reported strong prospective associations and evidence that early-life arsenic exposure is associated
with increases in lung, bladder, and kidney cancers as well as increased risk of myocardial infarction, chronic
renal disease, bronchiectasis, and respiratory symptoms. These associations were only evident decades after
the peak exposure period and persisted among the exposed population decades after mitigation measures were
taken. We are leveraging already collected samples from individuals exposed in early-life and unexposed
matched study participants to test for persistence of epigenetic disruption decades later in mid-life (median age
~ 50 years). We will evaluate if exposed individuals have accelerated epigenetic aging across multiple epigenetic
clocks that reflect different aspects of biological aging, morbidity, and mortality risk. Additionally, we will test if
exposed individuals have different estimates of leukocyte composition and DNA methylation signatures. We will
match and control for key covariates, such as current urinary arsenic levels, historical arsenic exposure in
adulthood, diet, smoking, BMI, sex, and socioeconomic status. This approach will enable us to test for latency
of epigenetic disruption captured in DNA methylation of leukocytes independent of recent and current arsenic
exposure. If successful, our study will demonstrate that exposure to arsenic during early-life can persistently
program epigenetic biomarkers that are strongly associated with morbidity and mortality decades later.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRENATAL AND POSTNATAL EXPOSURE TO ENVIRONMENTAL MIXTURES: NEURODEVELOPMENT AND DNA METHYLATION BIOMARKERS
-
批准号:10578793
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2022
-
负责人:Andres Cardenas
-
依托单位:
Common and Distinct Influences of Prenatal and Postnatal Early-Life Adversity on Epigenomic Trajectories in Mexican American Children
-
批准号:10523031
-
项目类别:
-
资助金额:$61.77万
-
财政年份:2022
-
负责人:Andres Cardenas
-
依托单位:
Common and Distinct Influences of Prenatal and Postnatal Early-Life Adversity on Epigenomic Trajectories in Mexican American Children
-
批准号:10851588
-
项目类别:
-
资助金额:$7.69万
-
财政年份:2022
-
负责人:Andres Cardenas
-
依托单位:
Common and Distinct Influences of Prenatal and Postnatal Early-Life Adversity on Epigenomic Trajectories in Mexican American Children
-
批准号:10665067
-
项目类别:
-
资助金额:$59.36万
-
财政年份:2022
-
负责人:Andres Cardenas
-
依托单位:
Prenatal and Postnatal Exposure to Environmental Mixtures: Neurodevelopment and DNA Methylation Biomarkers
-
批准号:10376348
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2020
-
负责人:Andres Cardenas
-
依托单位:
Prenatal and Postnatal Exposure to Environmental Mixtures: Neurodevelopment and DNA Methylation Biomarkers
-
批准号:10186748
-
项目类别:
-
资助金额:$42.54万
-
财政年份:2020
-
负责人:Andres Cardenas
-
依托单位:
Influence of Exposure to a Mixture of PFAS and Metals on the developing immune system
-
批准号:10349969
-
项目类别:
-
资助金额:$28.06万
-
财政年份:1997
-
负责人:Andres Cardenas
-
依托单位:
海外基金